The trial is continuing as planned and John Hopkins is continuing the treat patients as part of that that trial. The company is restricted from commenting too much on enrollment numbers.
- Forums
- ASX - By Stock
- Ann: Imricor Q4 CY24 Quarterly Activities Report and Appendix 4C
IMR
imricor medical systems inc.
Add to My Watchlist
2.16%
!
$1.59

The trial is continuing as planned and John Hopkins is...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.59 |
Change
-0.035(2.16%) |
Mkt cap ! $514.3M |
Open | High | Low | Value | Volume |
$1.63 | $1.63 | $1.59 | $231.7K | 143.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2078 | $1.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.60 | 26 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2284 | 1.585 |
1 | 844 | 1.575 |
1 | 15000 | 1.570 |
1 | 5355 | 1.560 |
4 | 12888 | 1.550 |
Price($) | Vol. | No. |
---|---|---|
1.595 | 26 | 1 |
1.600 | 2658 | 4 |
1.605 | 3 | 1 |
1.610 | 2300 | 1 |
1.630 | 5614 | 1 |
Last trade - 11.00am 16/06/2025 (20 minute delay) ? |
Featured News
IMR (ASX) Chart |